ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,468Medicare Part D Prescriptions Filled, Including Refills

Rank: 259 out of 1844

$584K Total Retail Price of All Prescriptions

Rank: 247 out of 1844

338 Patients Receiving at Least One Drug in Part D
51%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 338 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

27% of this provider’s 338 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 4,267 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 602 204 S3 1 2
OMEPRAZOLE 412 169 2 5
AMLODIPINE BESYLATE 259 176 3 6
LISINOPRIL 238 114 4 4
SIMVASTATIN 234 100 5 3
HYDROCHLOROTHIAZIDE 217 118 6 9
LEVOTHYROXINE SODIUM 204 113 7 1
FUROSEMIDE 153 72 8 7
ZOLPIDEM TARTRATE 151 48 9 23
PROAIR HFA 145 52 10 45
METFORMIN HCL 143 57 11 8
MELOXICAM 133 39 12 28
ATORVASTATIN CALCIUM 131 59 13 12
ATENOLOL 126 44 14 17
TRAMADOL HCL 126 19 14 18
GABAPENTIN 123 79 16 15
CYCLOBENZAPRINE HCL 116 18 R 17 53
CITALOPRAM HBR 106 73 18 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 102 69 19 20
METFORMIN HCL ER 91 43 20 46
AMITRIPTYLINE HCL 85 14 R 21 72
METOPROLOL SUCCINATE 84 42 22 14
POTASSIUM CHLORIDE 77 44 23 16
WARFARIN SODIUM 76 49 24 13
DONEPEZIL HCL 76 74 24 26
FLUOXETINE HCL 76 24 24 41
PROMETHAZINE HCL 72 30 R 27 88
KLOR-CON M20 69 23 28 54
NEXIUM 68 18 29 31
RANITIDINE HCL 68 45 29 38
NAMENDA 67 67 31 33
TAMSULOSIN HCL 67 66 31 27
TRAZODONE HCL 66 27 33 43
GLIMEPIRIDE 66 32 33 35
ENALAPRIL MALEATE 66 21 33 69
GLYBURIDE-METFORMIN HCL 60 29 R 36 140
LANTUS SOLOSTAR 60 38 36 97
METOPROLOL TARTRATE 59 35 38 11
SPIRIVA 55 11 39 57
LANTUS 54 24 40 42
PRAVASTATIN SODIUM 53 46 41 10
NAPROXEN 51 0 42 87
VENTOLIN HFA 51 13 42 145
COMBIVENT 50 0 44 131
CLONIDINE HCL 50 0 44 64
LOSARTAN-HYDROCHLOROTHIAZIDE 50 32 44 47
FENTANYL 50 17 S2 44 66
ALENDRONATE SODIUM 50 40 44 25
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 9, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.